Clinical Trial Update: Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of liposomal doxorubicin for brain metastases from breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Liposomal Doxorubicin (Lipo-Dox) (liposomal doxorubicin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED